Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Philips At HIMSS22: Informatics Is Taking Pressure Off Providers

The Reinvention Of Health Care Delivery Is Coming Closer

Executive Summary

Workplace pressures are hitting hospitals and providers still feeling the residual effects of the COVID-19 pandemic. Informatics and connected technologies can take much of the strain, said Royal Philips’ connected care chief Roy Jakobs.

You may also be interested in...



Digital Health Roundup: March Mad About Medtech Meetings; Telehealth Legislative Update

In this roundup feature focusing on new developments in digital health, Medtech Insight spotlights conference highlights from HIMSS, AAOS, Sensors Summit and legislative telehealth news.

HIMSS 2022: GE Introduces Edison Platform To Integrate Clinical Data From Multiple Sources

The Edison Digital Health Platform is a “vendor-agnostic” platform with an integrated AI engine that will allow health care systems to aggregate data from connect devices and other sources.

HIMSS 2022: Penumbra Previews Expanded VR Rehabilitation System For Stroke With Planned Launch In April

Penumbra is expanding its virtual reality-based platform technology to assist stroke patients and other rehabilitation patients with its new Real System Y-Series with marketing plans for April.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT145238

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel